These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 30400824)

  • 1. Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study.
    Linsalata M; Riezzo G; D'Attoma B; Clemente C; Orlando A; Russo F
    BMC Gastroenterol; 2018 Nov; 18(1):167. PubMed ID: 30400824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The obestatin/ghrelin ratio and ghrelin genetics in adult celiac patients before and after a gluten-free diet, in irritable bowel syndrome patients and healthy individuals.
    Russo F; Chimienti G; Linsalata M; Clemente C; Orlando A; Riezzo G
    Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):160-168. PubMed ID: 27750262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS.
    Russo F; Chimienti G; Riezzo G; Linsalata M; D'Attoma B; Clemente C; Orlando A
    Dis Markers; 2018; 2018():1827937. PubMed ID: 30622656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders.
    Mujagic Z; Ludidi S; Keszthelyi D; Hesselink MA; Kruimel JW; Lenaerts K; Hanssen NM; Conchillo JM; Jonkers DM; Masclee AA
    Aliment Pharmacol Ther; 2014 Aug; 40(3):288-97. PubMed ID: 24943095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Visceral sensitivity, gut barrier function and autonomic nerve function in patients with diarrhea-predominant irritable bowel syndrome].
    Xu X; Liu L; Yao S; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 May; 42(5):522-528. PubMed ID: 28626097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity.
    Prospero L; Riezzo G; Linsalata M; Orlando A; D'Attoma B; Di Masi M; Martulli M; Russo F
    BMC Gastroenterol; 2021 May; 21(1):235. PubMed ID: 34022802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.
    Singh P; Silvester J; Chen X; Xu H; Sawhney V; Rangan V; Iturrino J; Nee J; Duerksen DR; Lembo A
    United European Gastroenterol J; 2019 Jun; 7(5):709-715. PubMed ID: 31210949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.
    Rao AS; Camilleri M; Eckert DJ; Busciglio I; Burton DD; Ryks M; Wong BS; Lamsam J; Singh R; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G919-28. PubMed ID: 21836056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Levels of Circulating Biomarkers Related to Leaky Gut Syndrome and Bacterial Translocation Are Associated With Graves' Disease.
    Zheng D; Liao H; Chen S; Liu X; Mao C; Zhang C; Meng M; Wang Z; Wang Y; Jiang Q; Xue Y; Zhou L; Chen Y
    Front Endocrinol (Lausanne); 2021; 12():796212. PubMed ID: 34975767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between Markers of Gut Barrier Function and Erythrocyte Membrane PUFAs in Diarrhea-Predominant IBS Patients Undergoing a Low-FODMAP Diet.
    Linsalata M; Ignazzi A; D'Attoma B; Riezzo G; Mallardi D; Orlando A; Prospero L; Notarnicola M; De Nunzio V; Pinto G; Russo F
    Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution.
    Del Valle-Pinero AY; Van Deventer HE; Fourie NH; Martino AC; Patel NS; Remaley AT; Henderson WA
    Clin Chim Acta; 2013 Mar; 418():97-101. PubMed ID: 23328210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Biomarkers of Gut Barrier Function in Patients Suffering from Diarrhea Predominant-IBS: An Update.
    Linsalata M; Riezzo G; Clemente C; D'Attoma B; Russo F
    Dis Markers; 2020; 2020():2886268. PubMed ID: 33110455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intestinal barrier in irritable bowel syndrome: subtype-specific effects of the systemic compartment in an in vitro model.
    Ludidi S; Jonkers D; Elamin E; Pieters HJ; Schaepkens E; Bours P; Kruimel J; Conchillo J; Masclee A
    PLoS One; 2015; 10(5):e0123498. PubMed ID: 25978614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of Test for "Leaky Gut" Small Intestinal and Colonic Permeability Using Sugars in Healthy Adults.
    Khoshbin K; Khanna L; Maselli D; Atieh J; Breen-Lyles M; Arndt K; Rhoten D; Dyer RB; Singh RJ; Nayar S; Bjerkness S; Harmsen WS; Busciglio I; Camilleri M
    Gastroenterology; 2021 Aug; 161(2):463-475.e13. PubMed ID: 33865841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipokine profile in celiac patients: differences in comparison with patients suffering from diarrhea-predominant IBS and healthy subjects.
    Russo F; Chimienti G; Clemente C; D'Attoma B; Linsalata M; Orlando A; De Carne M; Cariola F; Semeraro FP; Pepe G; Riezzo G
    Scand J Gastroenterol; 2013 Dec; 48(12):1377-85. PubMed ID: 24164320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.
    Russo F; Linsalata M; Clemente C; D'Attoma B; Orlando A; Campanella G; Giotta F; Riezzo G
    BMC Cancer; 2013 Feb; 13():56. PubMed ID: 23379680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship between Low Serum Vitamin D Levels and Altered Intestinal Barrier Function in Patients with IBS Diarrhoea Undergoing a Long-Term Low-FODMAP Diet: Novel Observations from a Clinical Trial.
    Linsalata M; Riezzo G; Orlando A; D'Attoma B; Prospero L; Tutino V; Notarnicola M; Russo F
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An analysis for the clinical difference between post infectious irritable bowel syndrome and non post infectious irritable bowel syndrome].
    Shi H; Wan J; Liu W; Su B
    Zhonghua Nei Ke Za Zhi; 2015 Apr; 54(4):326-9. PubMed ID: 26268062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
    Rezaie A; Park SC; Morales W; Marsh E; Lembo A; Kim JH; Weitsman S; Chua KS; Barlow GM; Pimentel M
    Dig Dis Sci; 2017 Jun; 62(6):1480-1485. PubMed ID: 28451914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.
    Goo YA; Cain K; Jarrett M; Smith L; Voss J; Tolentino E; Tsuji J; Tsai YS; Panchaud A; Goodlett DR; Shulman RJ; Heitkemper M
    J Proteome Res; 2012 Dec; 11(12):5650-62. PubMed ID: 22998556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.